Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.

[1]  H. Putter,et al.  Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial. , 2020, International journal of radiation oncology, biology, physics.

[2]  H. Putter,et al.  Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Stockler,et al.  Preferences for Immunotherapy in Melanoma: A Systematic Review , 2019, Annals of Surgical Oncology.

[4]  R. Salazar,et al.  Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer , 2019, Clinical and Translational Oncology.

[5]  H. Putter,et al.  Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial , 2019, The Lancet. Oncology.

[6]  M. C. Vos,et al.  Recurrent Cancer Is Associated With Dissatisfaction With Care-A Longitudinal Analysis Among Ovarian and Endometrial Cancer Patients. , 2018, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[7]  M. Stockler,et al.  Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial , 2016, British Journal of Cancer.

[8]  H. Putter,et al.  Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial. , 2015, International journal of radiation oncology, biology, physics.

[9]  S. Kripalani,et al.  Validation of a Short, 3-Item Version of the Subjective Numeracy Scale , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  A. Stiggelbout,et al.  Patients' preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review. , 2014, Cancer treatment reviews.

[11]  A. Stiggelbout,et al.  Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians , 2014, British Journal of Cancer.

[12]  Lonneke V van de Poll-Franse,et al.  Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Siamak Noorbaloochi,et al.  Validation of Screening Questions for Limited Health Literacy in a Large VA Outpatient Population , 2008, Journal of General Internal Medicine.

[14]  H. Huizenga,et al.  Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  H. Huizenga,et al.  Do patients with localized prostate cancer treatment really want more aggressive treatment? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Graeff,et al.  Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice , 2003, British Journal of Cancer.

[17]  J. Baron,et al.  The Role of Physicians’ Recommendations in Medical Treatment Decisions , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  S. Jansen,et al.  Stability of Patients’ Preferences for Chemotherapy , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[19]  S. Jansen,et al.  Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? , 2001, British Journal of Cancer.

[20]  A. Zietman,et al.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.

[21]  A M Stiggelbout,et al.  Patient preference for cancer therapy: an overview of measurement approaches. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. de Haes,et al.  Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists' preferences. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.